The role of amyloid PET in patient selection for extra-ventricular shunt insertion for the treatment of idiopathic normal pressure hydrocephalus : A pooled analysis
Copyright © 2021 Elsevier Ltd. All rights reserved..
BACKGROUND: Idiopathic Normal Pressure Hydrocephalus (iNPH) can be effectively treated through shunt insertion. However, most shunted patients experience little or no clinical benefit, which suggests suboptimal patient selection. While contentious, multiple studies have reported poorer shunt outcomes associated with concomitant Alzheimer's disease. Prompted by this observation, multiple studies have assessed the role of amyloid PET, a specific test for Alzheimer's disease, in patient selection for shunting.
METHODS: A comprehensive literature search was performed to identify studies that assessed the association between amyloid PET result and the clinical response to shunting in patients with suspected iNPH. Pooled diagnostic statistics were calculated.
RESULTS: Across three relevant studies, a total of 38 patients with suspected iNPH underwent amyloid PET imaging and shunt insertion. Twenty-three patients had a positive clinical response to shunting. 18/28 (64.3%) of patients with a negative amyloid PET and 5/10 (50%) with a positive amyloid PET had a positive response to shunting. The pooled sensitivity, specificity and accuracy was 33.3%, 76.2% and 58.3%. None of these statistics reached statistical significance.
CONCLUSION: The results of this pooled analysis do not support the selection of patients with suspected iNPH for shunting on the basis of amyloid PET alone. However, due to small cohort sizes and weakness in study design, further high-quality studies are required to properly determine the role of amyloid PET in assessing this complex patient group.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:90 |
---|---|
Enthalten in: |
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia - 90(2021) vom: 20. Aug., Seite 325-331 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mallon, Dermot H [VerfasserIn] |
---|
Links: |
---|
Themen: |
Alzheimer’s disease |
---|
Anmerkungen: |
Date Completed 23.07.2021 Date Revised 23.07.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jocn.2021.06.017 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM328209317 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM328209317 | ||
003 | DE-627 | ||
005 | 20231225202453.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jocn.2021.06.017 |2 doi | |
028 | 5 | 2 | |a pubmed24n1093.xml |
035 | |a (DE-627)NLM328209317 | ||
035 | |a (NLM)34275571 | ||
035 | |a (PII)S0967-5868(21)00312-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mallon, Dermot H |e verfasserin |4 aut | |
245 | 1 | 4 | |a The role of amyloid PET in patient selection for extra-ventricular shunt insertion for the treatment of idiopathic normal pressure hydrocephalus |b A pooled analysis |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.07.2021 | ||
500 | |a Date Revised 23.07.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 Elsevier Ltd. All rights reserved. | ||
520 | |a BACKGROUND: Idiopathic Normal Pressure Hydrocephalus (iNPH) can be effectively treated through shunt insertion. However, most shunted patients experience little or no clinical benefit, which suggests suboptimal patient selection. While contentious, multiple studies have reported poorer shunt outcomes associated with concomitant Alzheimer's disease. Prompted by this observation, multiple studies have assessed the role of amyloid PET, a specific test for Alzheimer's disease, in patient selection for shunting | ||
520 | |a METHODS: A comprehensive literature search was performed to identify studies that assessed the association between amyloid PET result and the clinical response to shunting in patients with suspected iNPH. Pooled diagnostic statistics were calculated | ||
520 | |a RESULTS: Across three relevant studies, a total of 38 patients with suspected iNPH underwent amyloid PET imaging and shunt insertion. Twenty-three patients had a positive clinical response to shunting. 18/28 (64.3%) of patients with a negative amyloid PET and 5/10 (50%) with a positive amyloid PET had a positive response to shunting. The pooled sensitivity, specificity and accuracy was 33.3%, 76.2% and 58.3%. None of these statistics reached statistical significance | ||
520 | |a CONCLUSION: The results of this pooled analysis do not support the selection of patients with suspected iNPH for shunting on the basis of amyloid PET alone. However, due to small cohort sizes and weakness in study design, further high-quality studies are required to properly determine the role of amyloid PET in assessing this complex patient group | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Alzheimer’s disease | |
650 | 4 | |a Amyloid PET | |
650 | 4 | |a CSF diversion | |
650 | 4 | |a Neurodegenerative disease | |
650 | 4 | |a Normal pressure hydrocephalus | |
650 | 4 | |a Shunt insertion | |
650 | 7 | |a Amyloid |2 NLM | |
700 | 1 | |a Malhotra, Paresh |e verfasserin |4 aut | |
700 | 1 | |a Naik, Mitesh |e verfasserin |4 aut | |
700 | 1 | |a Edison, Paul |e verfasserin |4 aut | |
700 | 1 | |a Perry, Richard |e verfasserin |4 aut | |
700 | 1 | |a Carswell, Christopher |e verfasserin |4 aut | |
700 | 1 | |a Win, Zarni |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia |d 1994 |g 90(2021) vom: 20. Aug., Seite 325-331 |w (DE-627)NLM093767099 |x 1532-2653 |7 nnns |
773 | 1 | 8 | |g volume:90 |g year:2021 |g day:20 |g month:08 |g pages:325-331 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jocn.2021.06.017 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 90 |j 2021 |b 20 |c 08 |h 325-331 |